REFERENCES
- Elikkottil J, Gupta P, Gupta K. The analgesic potential of cannabinoids. J Opioid Manag. 2009;5:341–357.
- Health Canada. Fact sheet—medical access to marihuana. 2008. Available at: http://www.hsc.gc.ca/dhpmps/marihuana/law-loi/ fact_sheet-infofiche-eng.php. Accessed May 31, 2011.
- Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383–1391.
- Grotenhermen F. The toxicology of cannabis and cannabis prohibition. Chem Biodivers. 2007;4:1744–1769.
- Moir D, Rickert WS, Levasseur G, A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008;21:494–502.
- Dragt S, Nieman DH, Becker HE, Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry. 2010;55:165–171.
- Ebell MH, Siwek J, Weiss BD, Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004;17:59–67.
- Bocker KB, Gerritsen J, Hunault CC, Kruidenier M, Mensinga TT, Kenemans JL. Cannabis with high Delta(9)-THC contents affects perception and visual selective attention acutely: an event-related potential study. Pharmacol Biochem Behav. 2010;96:67–74.